Massachusetts Financial Services CO Abcam PLC Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$21.54 - $24.41 $10.6 Million - $12 Million	-491,949 Reduced 19.63%	2,014,118 $45.6 Million
Q2 2023 Aug 09, 2023	SELL	$12.62 - $24.47 $12.8 Million - $24.9 Million	-1,017,998 Reduced 28.89%	2,506,067 $61.3 Million
Q1 2023 May 10, 2023	BUY	$12.98 - $17.1 $7.61 Million - $10 Million	586,266 Added 19.96%	3,524,065 $47.4 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $40.9 Million - $49.9 Million	2,937,799 New	2,937,799 $45.7 Million
Q1 2021 May 13, 2021	SELL	$19.22 - $24.3 $7.8 Million - $9.86 Million	-405,730 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.2 - $22.45 $7.38 Million - $9.11 Million	405,730 New	405,730 $8.74 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.